Loading publications…
The last 5 uploaded publications
Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Daniela Sia, Bojan Losic, Agrin Moeini, Laia Cabellos, Ke Hao, Kate Revill, Dennis M. Bonal, Oriana Miltiadous, Zhongyang Zhang, Yujin Hoshida, Helena Cornellà, Mireia Castillo-Martín, Roser Pinyol, Yumi Kasai, Sasan Roayaie, Swan N. Thung, Josep Fuster, Myron Schwartz, Samuel Waxman, Carlos Cordon‐Cardo, Eric E. Schadt, Vincenzo Mazzaferro, Josep M. Llovet (2015). Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nature Communications, 6(1), DOI: 10.1038/ncomms7087.
Article145 days agoWnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
Anja Lachenmayer, Clara Alsinet, Radoslav Savić, Laia Cabellos, Sara Toffanin, Yujin Hoshida, Augusto Villanueva, Beatriz Mínguez, Philippa Newell, Hung‐Wen Tsai, Jordi Barretina, Swan N. Thung, Stephen C. Ward, Jordi Bruix, Vincenzo Mazzaferro, Myron Schwartz, Scott L. Friedman, Josep M. Llovet (2012). Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib. Clinical Cancer Research, 18(18), pp. 4997-5007, DOI: 10.1158/1078-0432.ccr-11-2322.
Article145 days agoMolecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Robert Montal, Daniela Sia, Carla Montironi, Wei Qiang Leow, Roger Esteban-Fabró, Roser Pinyol, Miguel Torres‐Martín, Laia Bassaganyas, Agrin Moeini, Judit Peix, Laia Cabellos, Miho Maeda, Carlos Villacorta-Martín, Parissa Tabrizian, Leonardo Rodríguez‐Carunchio, Giancarlo Castellano, Christine Sempoux, Beatriz Mínguez, Timothy M. Pawlik, Ismaïl Labgaa, Lewis R. Roberts, Manel Solé, Maria Isabel Fiel, Swan N. Thung, Josep Fuster, Sasan Roayaie, Augusto Villanueva, M. Schwartz, Josep M. Llovet (2020). Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. Journal of Hepatology, 73(2), pp. 315-327, DOI: 10.1016/j.jhep.2020.03.008.
Article145 days agoTumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Victoria Tovar, Helena Cornellà, Agrin Moeini, Samuel J. Vidal, Yujin Hoshida, Daniela Sia, Judit Peix, Laia Cabellos, Clara Alsinet, Sara Torrecilla, Iris Martinez-Quetglas, Juan José Lozano, Christèle Desbois‐Mouthon, Manel Solé, Josep Domingo-Domènech, Augusto Villanueva, Josep M. Llovet (2015). Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut, 66(3), pp. 530-540, DOI: 10.1136/gutjnl-2015-309501.
Article145 days agoMicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
Sara Toffanin, Yujin Hoshida, Anja Lachenmayer, Augusto Villanueva, Laia Cabellos, Beatriz Mínguez, Radoslav Savić, Stephen C. Ward, Swan N. Thung, Derek Y. Chiang, Clara Alsinet, Victoria Tovar, Sasan Roayaie, Myron Schwartz, Jordi Bruix, Samuel Waxman, Scott L. Friedman, Todd R. Golub, Vincenzo Mazzaferro, Josep M. Llovet (2011). MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a. Gastroenterology, 140(5), pp. 1618-1628.e16, DOI: 10.1053/j.gastro.2011.02.009.
Article145 days ago